Skip to main content
OpenTrials
Completed

NCT Number: NCT05807958

Allergy Testing of Soldiers Prepared for International Mission

The goal of this prospective mono centric study is to identify relevant commercially available allergen extracts for allergy testing in soldiers prepared for international mission.

Participants will receive a skin prick test with the skin prick automated test device including 22 allergens and 2 controls on both forearms.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Military Hospital Queen Astrid

Brussels, 1120, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult military personnel (18-65y) will be included. Soldiers with and without previous exposure to allergens in the regions of interest will be included. Soldiers who are performing desk tasks and not selected for international missions will serve as controls.

Exclusion criteria

  • Skin pathology like chronic or exuberant urticaria, dermographism, chronic dermatitis that needs daily treatment
  • Use of antihistaminic medication < 7 days before the start of the study
  • Use of tricyclic antidepressants (antihistamine activity) < 7 days before the start of the study
  • Use of topical corticoids on the forearm < 7 days before the start of the study
  • Use of Omalizumab < 6 months before the start of the study
  • Pregnancy: there is a remote possibility of inducing a systemic allergic reaction that could induce uterine contractions or necessitate the use of epinephrine (thought to cause constriction of the umbilical artery).

Treatment and study plan

Skin Prick Automated Test

Device

A skin prick automated test will be performed in each participant.

Primary outcomes

  1. Allergens with positive skin reaction

    Time frame: baseline

    Positive skin reactions of top ranked allergens required to identify 95% of sensitised individuals

Secondary outcomes

  1. Self-reported allergic diseases

    Time frame: baseline

    Percentage of soldiers with self-reported allergic diseases derived from questionnaire

  2. Work Performance & Activity Impairment

    Time frame: baseline

    Total score of Work Performance & Activity Impairment questionnaire, 0-100%, higher score means worse outcome

Sponsors and collaborators

Lead sponsor

Queen Astrid Military Hospital

Other

Registry information

Official study title

Validation of the Benefit of Allergy Testing of Soldiers Prepared for International Mission With Specific Allergen Panels

Acronym: SPAT_ABL

Important dates

Study start
2023
Primary completion
2024
Study completion
2025
First posted
Apr 11, 2023
Registry last updated
Feb 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.